Carisma Therapeutics, Inc.
CARM
$0.2153
$0.00180.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.64M | -12.70M | -11.16M | -18.98M | -20.96M |
| Total Depreciation and Amortization | 669.00K | 737.00K | 255.00K | 1.69M | 722.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 607.00K | 2.08M | 3.75M | 2.72M | 2.05M |
| Change in Net Operating Assets | 8.01M | -3.13M | -8.97M | -7.86M | 2.09M |
| Cash from Operations | -8.35M | -13.02M | -16.12M | -22.43M | -16.10M |
| Capital Expenditure | 0.00 | 0.00 | -106.00K | -17.00K | -561.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 11.00M |
| Cash from Investing | 0.00 | 0.00 | -106.00K | -17.00K | 10.44M |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 686.00K | 0.00 |
| Total Debt Repaid | -597.00K | -590.00K | 71.00K | -1.62M | -591.00K |
| Issuance of Common Stock | -- | 129.00K | 2.00K | 2.29M | 692.00K |
| Repurchase of Common Stock | -23.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -620.00K | -461.00K | 73.00K | 1.35M | 101.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.97M | -13.48M | -16.15M | -21.09M | -5.56M |